Welcome to the InfoSci Platform
Reference Hub1
First Report on the Validated Classification-Based Chemometric Modeling of Human Rhinovirus 3C Protease (HRV 3Cpro) Inhibitors

First Report on the Validated Classification-Based Chemometric Modeling of Human Rhinovirus 3C Protease (HRV 3Cpro) Inhibitors

Sk. Abdul Amin, Nilanjan Adhikari, Shovanlal Gayen, Tarun Jha
Copyright: © 2018 |Volume: 3 |Issue: 2 |Pages: 20
ISSN: 2379-7487|EISSN: 2379-7479|EISBN13: 9781522547242|DOI: 10.4018/IJQSPR.2018070101
Cite Article Cite Article

MLA

Amin, Sk. Abdul, et al. "First Report on the Validated Classification-Based Chemometric Modeling of Human Rhinovirus 3C Protease (HRV 3Cpro) Inhibitors." IJQSPR vol.3, no.2 2018: pp.1-20. http://doi.org/10.4018/IJQSPR.2018070101

APA

Amin, S. A., Adhikari, N., Gayen, S., & Jha, T. (2018). First Report on the Validated Classification-Based Chemometric Modeling of Human Rhinovirus 3C Protease (HRV 3Cpro) Inhibitors. International Journal of Quantitative Structure-Property Relationships (IJQSPR), 3(2), 1-20. http://doi.org/10.4018/IJQSPR.2018070101

Chicago

Amin, Sk. Abdul, et al. "First Report on the Validated Classification-Based Chemometric Modeling of Human Rhinovirus 3C Protease (HRV 3Cpro) Inhibitors," International Journal of Quantitative Structure-Property Relationships (IJQSPR) 3, no.2: 1-20. http://doi.org/10.4018/IJQSPR.2018070101

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

Human rhinoviruses (HRVs), a major cause of common cold and upper respiratory infections, may trigger severe respiratory complications like asthma and COPD. To date, no drugs are available in the market which are designed as novel HRV inhibitors despite the involvement of some pharmaceutical companies' due to economical and clinical constraints. HRV 3C protease may be a potential target for drug design as it plays crucial role in viral RNA replication and virion assembly process. Therefore, designing novel HRV 3Cpro inhibitors is necessary and demanding in the field of antiviral drug design. In this article, statistically significant and validated classification-based QSARs of a series of HRV 3Cpro inhibitors were performed for the first time as per the authors' knowledge. Results suggest that oxopyrrolidine and piperidinone rings are favored whereas carboxybenzyl and unsubstituted benzyl functions may be unfavorable. Moreover, this group, along with cyclic alkyl or aryl ring structures may favor HRV 3Cpro inhibition. These observations may be utilized for the design of a higher active anti-HRV agent in future.

Data Sets

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.